期刊文献+

二甲双胍在肿瘤治疗中的研究进展 被引量:3

Research progress of metformin in tumor therapy
下载PDF
导出
摘要 目的综述二甲双胍在肿瘤治疗中的作用机制与最新进展。方法通过搜索“二甲双胍”“抗肿瘤”“作用机制”等关键词,运用SciFinder、Elsevier、Web of Science、中国知网、万方等数据库,查阅了相关文献,并对其进行了归纳、分析和总结。结果二甲双胍有多种潜在的抗肿瘤作用机制,对乳腺癌、卵巢癌、前列腺癌和肝癌等都具有明显的抑制作用。结论二甲双胍的抗肿瘤作用具有广阔的研究前景,可以为癌症治疗提供新的治疗方案与思路。 Objective To review the mechanism and latest progress of metformin in cancer treatment.Methods By searching for keywords such as“metformin”,“anti-tumor”,“mechanism of action”,etc.,using SciFinder,Elsevier,Web of Science,CNKI,WanFang Data and other databases,we read and reviewed the relevant literatures and carried out induction,analysis and summary.Results Metformin has a variety of potential anti-tumor mechanisms,and it has obvious inhibitory effects on different kinds of cancer such as breast cancer,ovarian cancer,prostate cancer and liver cancer.Conclusions The antitumor effect of metformin has broad research prospects and can provide new treatment options and ideas for cancer treatment.
作者 孙萌 王东凯 SUN Meng;WANG Dongkai(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《中国药剂学杂志》 2021年第1期28-34,共7页 Chinese Journal of Pharmaceutics
关键词 药剂学 综述 肿瘤治疗 二甲双胍 pharmaceutics review tumor therapy metformin
  • 相关文献

参考文献3

二级参考文献25

  • 1Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients[J].BMJ, 2005, 330 (7503): 1304-1305.
  • 2Bhalla K, Hwang BJ, Dewi RE, et al. Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis[J].Cancer Prev Res (Phila), 2012, 5( 4): 544-552.
  • 3Qu Z, Zhang Y, Liao M, et al. In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma[J].Hepatol Res, 2012, 42(9): 922-933.
  • 4Zhang ZJ, Zheng ZJ, Shi R, et al. Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis[J].J Clin Endocrinol Metab , 2012, 97(7): 2347-2353.
  • 5El-Serag HB. Hepatocellular carcinoma: recent trends in the United States[J].Gastroenterology, 2004, 127(5 Suppl 1): S27-S34.
  • 6Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis[J].Cancer Prev Res, 2010, 3(11): 1451-1461.
  • 7El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans[J].Am J Gastroenterol, 2001, 96(8): 2462-2467.
  • 8Rahman MT, Nakayama K, Ishikawa M, et al. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cance[J].Oncology, 2013, 84(3): 166-173.
  • 9Biochemi KZ, Medyczny GU. Metabolic and regulatory function of fatty acid synthase [J].Postepy Biochem, 2012, 58(2): 175-185.
  • 10Polesel J, Zucchetto A, Montella M, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma[J].Ann Oncol, 2009, 20(2): 353-357.

共引文献17

同被引文献37

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部